Quick Results
Press Releases

Baker Donelson Adds Jean Frydman to Intellectual Property Group

Share

Baker Donelson has added Jean W. Frydman, an experienced food and drug law attorney, to its Intellectual Property Group.

Ms. Frydman, who joins as of counsel in the Firm's Baltimore office, has served as general counsel for multinational pharmaceutical companies and a multinational retail dietary supplement company. She has significant experience handling regulatory compliance matters for both private and publicly held pharmaceutical, medical device and dietary supplement companies, regularly providing strategic legal counsel and compliance reports to boards of directors and serving as a trusted legal adviser to executive management and business leaders. Ms. Frydman has extensive experience advising senior management on new Food and Drug Administration (FDA) rules, proactive submissions to the FDA, USDA and Current Good Manufacturing Practice (cGMP) compliance and other significant enforcement issues.

"Jean brings more than 30 years of in-house experience to our group and possesses an in-depth knowledge of food and drug law, including regulatory and compliance issues facing clients from a variety of industries," said Edward Ramage, co-chair of Baker Donelson's Intellectual Property Group. "Her understanding of the regulatory environment clients are facing will allow us to better serve our clients, making her a tremendous asset to our team."

A frequent author and speaker on FDA-related issues, Ms. Frydman is a member of the Food and Drug Law Institute where she serves on the Academic Programs Committee. Prior to joining Baker Donelson, she served as chair of the FDA practice of a major multi-national law firm. Ms. Frydman is a member of the New Jersey Chapter of the American Corporate Counsel Association, the Regulatory Affairs Professionals Society and the American Bar Association. She is a graduate of the Chicago-Kent College of Law.

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept